Advanced biomaterials and microengineering technologies to recapitulate the stepwise process of cancer metastasis

Biomaterials

Volumn 133, Issue , 2017, Pages 176-207

  Peela, Nitish ^a   Truong, Danh ^a   Saini, Harpinder ^a   Chu, Hunghao ^b   Mashaghi, Samaneh ^b   Ham, Stephanie L ^c   Singh, Sunil ^c   Tavana, Hossein ^c   Mosadegh, Bobak ^b   Nikkhah, Mehdi ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c University of Akron   (United States)

Author keywords

Angiogenesis; Biomaterials; Extravasation; Intravasation; Microengineering technologies; Microfluidics; Tumor model

Indexed keywords

BIOMATERIALS; BIOMIMETIC PROCESSES; DIAGNOSIS; ENZYME ACTIVITY; ENZYME INHIBITION; MICROFLUIDICS; PATHOLOGY; PHYSIOLOGICAL MODELS; TUMORS;

ANGIOGENESIS; EXTRAVASATION; INTRAVASATION; MICRO-ENGINEERING TECHNOLOGY; TUMOR MODELS;

DISEASES;

ANTINEOPLASTIC AGENT; BIOMATERIAL;

BIOENGINEERING; CANCER CELL; CANCER GROWTH; CANCER LOCALIZATION; CANCER MODEL; CELL MOTILITY; DRUG SCREENING; HUMAN; IN VITRO STUDY; METASTASIS; MICROTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR INTRAVASATION; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ANIMAL; BREAST TUMOR; CHEMISTRY; MICROFLUIDICS; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; BIOCOMPATIBLE MATERIALS; BREAST NEOPLASMS; HUMANS; MICROFLUIDICS; NEOPLASM METASTASIS; TUMOR MICROENVIRONMENT;

EID: 85018482929     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2017.04.017     Document Type: Review

References (316)

1. [1] Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016. CA A Cancer J. Clin. 66:1 (2016), 7–30.
2. [2] McMillin, D.W., Negri, J.M., Mitsiades, C.S., The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat. Rev. Drug Discov. 12:3 (2013), 217–228.
3. [3] Yokota, J., Tumor progression and metastasis. Carcinogenesis 21:3 (2000), 497–503.
4. [4] Kalluri, R., Zeisberg, M., Fibroblasts in cancer. Nat. Rev. Cancer 6:5 (2006), 392–401.
5. [5] Joyce, J.A., Pollard, J.W., Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9:4 (2009), 239–252.
6. [6] Robinson, B.D., Sica, G.L., Liu, Y.F., Rohan, T.E., Gertler, F.B., Condeelis, J.S., Jones, J.G., Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin. cancer Res. Off. J. Am. Assoc. Cancer Res. 15:7 (2009), 2433–2441.
7. [7] De Wever, O., Mareel, M., Role of tissue stroma in cancer cell invasion. J. Pathol. 200:4 (2003), 429–447.
8. [8] Lu, P., Weaver, V.M., Werb, Z., The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196:4 (2012), 395–406.
9. [9] Li, H., Fan, X., Houghton, J., Tumor microenvironment: the role of the tumor stroma in cancer. J. Cell. Biochem. 101:4 (2007), 805–815.
10. [10] Khamis, Z.I., Sahab, Z.J., Sang, Q.X.A., Active roles of tumor stroma in breast cancer metastasis. Int. J. Breast Cancer, 2012, 2012.
11. [11] Richmond, A., Su, Y., Mouse xenograft models vs GEM models for human cancer therapeutics. Dis. Models Mech. 1:2–3 (2008), 78–82.
12. [12] Mak, I.W.Y., Evaniew, N., Ghert, M., Lost in translation: animal models and clinical trials in cancer treatment. Am. J. Transl. Res. 6:2 (2014), 114–118.
13. [13] Benam, K.H., Dauth, S., Hassell, B., Herland, A., Jain, A., Jang, K.J., Karalis, K., Kim, H.J., MacQueen, L., Mahmoodian, R., Musah, S., Torisawa, Y.S., Meer, A.D.v.d., Villenave, R., Yadid, M., Parker, K.K., Ingber, D.E., Engineered in vitro disease models. Annu. Rev. Pathol. Mech. Dis. 10:1 (2015), 195–262.
14. [14] Infanger, D.W., Lynch, M.E., Fischbach, C., Engineered culture models for studies of tumor-microenvironment interactions. Annu. Rev. Biomed. Eng. 15:1 (2013), 29–53.
15. [15] Verma, M., Personalized medicine and cancer. J. Pers. Med. 2:1 (2012), 1–14.
16. [16] Weaver, V.M., Petersen, O.W., Wang, F., Larabell, C.A., Briand, P., Damsky, C., Bissell, M.J., Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol., 137, 1997.
17. [17] Weigelt, B., Ghajar, C.M., Bissell, M.J., The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Adv. Drug Deliv. Rev. 69–70 (2014), 42–51.
18. [18] Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., Kunz-Schughart, L.A., Multicellular tumor spheroids: an underestimated tool is catching up again. J. Biotechnol. 148:1 (2010), 3–15.
19. [19] Benton, G., Arnaoutova, I., George, J., Kleinman, H.K., Koblinski, J., Matrigel: from discovery and ECM mimicry to assays and models for cancer research. Adv. Drug Deliv. Rev. 79–80 (2014), 3–18.
20. [20] Serban, M.A., Prestwich, G.D., Modular extracellular matrices: solutions for the puzzle. Methods 45:1 (2008), 93–98.
21. [21] Patel, R., Alahmad, A.J., Growth-factor reduced Matrigel source influences stem cell derived brain microvascular endothelial cell barrier properties. Fluids Barriers CNS, 13(1), 2016, 6.
22. [22] Hughes, C.S., Postovit, L.M., Lajoie, G.A., Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10:9 (2010), 1886–1890.
23. [23] Gill, B.J., West, J.L., Modeling the tumor extracellular matrix: tissue engineering tools repurposed towards new frontiers in cancer biology. J. Biomech. 47:9 (2014), 1969–1978.
24. [24] Gurski, L.A., Jha, A.K., Zhang, C., Jia, X., Farach-Carson, M.C., Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 30:30 (2009), 6076–6085.
25. [25] Loessner, D., Stok, K.S., Lutolf, M.P., Hutmacher, D.W., Clements, J.A., Rizzi, S.C., Bioengineered 3D platform to explore cell–ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 31:32 (2010), 8494–8506.
26. [26] Sung, K.E., Beebe, D.J., Microfluidic 3D models of cancer. Adv. Drug Deliv. Rev. 0 (2014), 68–78.
27. [27] Truong, D., Puleo, J., Llave, A., Mouneimne, G., Kamm, R.D., Nikkhah, M., Breast cancer cell invasion into a three dimensional tumor-stroma microenvironment. Sci. Rep., 6, 2016, 34094.
28. [28] Peela, N., Sam, F.S., Christenson, W., Truong, D., Watson, A.W., Mouneimne, G., Ros, R., Nikkhah, M., A three dimensional micropatterned tumor model for breast cancer cell migration studies. Biomaterials 81 (2016), 72–83.
29. [29] Nelson, C.M., VanDuijn, M.M., Inman, J.L., Fletcher, D.A., Bissell, M.J., Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science 314:5797 (2006), 298–300.
30. [30] Lee, V.K., Kim, D.Y., Ngo, H., Lee, Y., Seo, L., Yoo, S.S., Vincent, P.A., Dai, G., Creating perfused functional vascular channels using 3D bio-printing technology. Biomaterials 35:28 (2014), 8092–8102.
31. [31] Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144:5 (2011), 646–674.
32. [32] Nguyen, A., Yoshida, M., Goodarzi, H., Tavazoie, S.F., Highly variable cancer subpopulations that exhibit enhanced transcriptome variability and metastatic fitness. Nat. Commun., 7, 2016, 11246.
33. [33] Hanahan, D., Weinberg, R.A., The hallmarks of cancer. Cell 100:1 (2000), 57–70.
34. [34] Cooper, G.M., The Development and Causes of Cancer, the Cell: a Molecular Approach. 2000, Sinauer Associates, Sunderland (MA).
35. [35] Schaefer, M.H., Serrano, L., Cell type-specific properties and environment shape tissue specificity of cancer genes. Sci. Rep., 6, 2016, 20707.
36. [36] Lee, M., Vasioukhin, V., Cell polarity and cancer - cell and tissue polarity as a non-canonical tumor suppressor. J. Cell Sci. 121:8 (2008), 1141–1150.
37. [37] Wodarz, A., Näthke, I., Cell polarity in development and cancer. Nat. Cell Biol. 9:9 (2007), 1016–1024.
38. [38] Butcher, D.T., Alliston, T., Weaver, V.M., A tense situation: forcing tumour progression, Nature reviews. Cancer 9:2 (2009), 108–122.
39. [39] Kalluri, R., Weinberg, R.A., The basics of epithelial-mesenchymal transition. J. Clin. Investig. 119:6 (2009), 1420–1428.
40. [40] Yamaguchi, H., Condeelis, J., Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochimica. Biophys. Acta (BBA) - Mol. Cell Res. 1773:5 (2007), 642–652.
41. [41] Mbeunkui, F., Johann, D.J., Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother. Pharmacol. 63:4 (2009), 571–582.
42. [42] Cirri, P., Chiarugi, P., Cancer associated fibroblasts: the dark side of the coin. Am. J. Cancer Res., 1(4), 2011, 482.
43. [43] Orimo, A., Gupta, P.B., Sgroi, D.C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V.J., Richardson, A.L., Weinberg, R.A., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:3 (2005), 335–348.
44. [44] Watnick, R.S., The role of the tumor microenvironment in regulating angiogenesis. Cold Spring Harb. Perspect. Med., 2(12), 2012 a006676.
45. [45] Gajewski, T.F., Schreiber, H., Fu, Y.-X., Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14:10 (2013), 1014–1022.
46. [46] Kitamura, T., Qian, B.Z., Pollard, J.W., Immune cell promotion of metastasis. Nat. Rev. Immunol. 15:2 (2015), 73–86.
47. [47] Nyga, A., Cheema, U., Loizidou, M., 3D tumour models: novel in vitro approaches to cancer studies. J. Cell Commun. Signal. 5:3 (2011), 239–248.
48. [48] Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., Court, W., Lomas, C., Mendiola, M., Hardisson, D., Eccles, S.A., Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol., 10(1), 2012, 29.
49. [49] Powell, C.D., Paullin, T.R., Aoisa, C., Menzie, C.J., Ubaldini, A., Westerheide, S.D., The heat shock transcription factor HSF1 induces ovarian cancer epithelial-mesenchymal transition in a 3D spheroid growth model. PLoS One, 11(12), 2016, e0168389.
50. [50] Ware, M.J., Keshishian, V., Law, J.J., Ho, J.C., Favela, C.A., Rees, P., Smith, B., Mohammad, S., Hwang, R.F., Rajapakshe, K., Coarfa, C., Huang, S., Edwards, D.P., Corr, S.J., Godin, B., Curley, S.A., Generation of an in vitro 3D PDAC stroma rich spheroid model. Biomaterials 108 (2016), 129–142.
51. [51] Marrero, B., Messina, J.L., Heller, R., Generation of a tumor spheroid in a microgravity environment as a 3D model of melanoma. In Vitro Cell. Dev. Biol. - Anim. 45:9 (2009), 523–534.
52. [52] Costa, E.C., Gaspar, V.M., Coutinho, P., Correia, I.J., Optimization of liquid overlay technique to formulate heterogenic 3D co-cultures models. Biotechnol. Bioeng. 111:8 (2014), 1672–1685.
53. [53] Akasov, R., Gileva, A., Zaytseva-Zotova, D., Burov, S., Chevalot, I., Guedon, E., Markvicheva, E., 3D in vitro co-culture models based on normal cells and tumor spheroids formed by cyclic RGD-peptide induced cell self-assembly. Biotechnol. Lett. 39:1 (2017), 45–53.
54. [54] Mehta, G., Hsiao, A.Y., Ingram, M., Luker, G.D., Takayama, S., Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J. Control. Release 164:2 (2012), 192–204.
55. [55] Liu, T., Chien, C.C., Parkinson, L., Thierry, B., Advanced micromachining of concave microwells for long term on-chip culture of multicellular tumor spheroids. ACS Appl. Mater. Interfaces 6:11 (2014), 8090–8097.
56. [56] Singh, M., Close, D.A., Mukundan, S., Johnston, P.A., Sant, S., Production of uniform 3D microtumors in hydrogel microwell arrays for measurement of viability, morphology, and signaling pathway activation. Assay Drug Dev. Technol. 13:9 (2015), 570–583.
57. [57] Tang, Y., Liu, J., Chen, Y., Agarose multi-wells for tumour spheroid formation and anti-cancer drug test. Microelectron. Eng. 158 (2016), 41–45.
58. [58] Ma, J., Zhang, X., Liu, Y., Yu, H., Liu, L., Shi, Y., Li, Y., Qin, J., Patterning hypoxic multicellular spheroids in a 3D matrix - a promising method for anti-tumor drug screening. Biotechnol. J. 11:1 (2016), 127–134.
59. [59] Weiswald, L.B., Bellet, D., Dangles-Marie, V., Spherical cancer models in tumor biology. Neoplasia 17:1 (2015), 1–15.
60. [60] Szot, C.S., Buchanan, C.F., Freeman, J.W., Rylander, M.N., 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials 32:31 (2011), 7905–7912.
61. [61] Boghaert, E., Gleghorn, J.P., Lee, K., Gjorevski, N., Radisky, D.C., Nelson, C.M., Host epithelial geometry regulates breast cancer cell invasiveness. Proc. Natl. Acad. Sci. 109:48 (2012), 19632–19637.
62. [62] Kaemmerer, E., Melchels, F.P.W., Holzapfel, B.M., Meckel, T., Hutmacher, D.W., Loessner, D., Gelatine methacrylamide-based hydrogels: an alternative three-dimensional cancer cell culture system. Acta Biomater. 10:6 (2014), 2551–2562.
63. [63] Nikkhah, M., Eshak, N., Zorlutuna, P., Annabi, N., Castello, M., Kim, K., Dolatshahi-Pirouz, A., Edalat, F., Bae, H., Yang, Y., Khademhosseini, A., Directed endothelial cell morphogenesis in micropatterned gelatin methacrylate hydrogels. Biomaterials 33:35 (2012), 9009–9018.
64. [64] Nichol, J.W., Koshy, S., Bae, H., Hwang, C.M., Yamanlar, S., Khademhosseini, A., Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials 31:21 (2010), 5536–5544.
65. [65] Navaei, A., Saini, H., Christenson, W., Sullivan, R.T., Ros, R., Nikkhah, M., Gold nanorod-incorporated gelatin-based conductive hydrogels for engineering cardiac tissue constructs. Acta Biomater. 41 (2016), 133–146.
66. [66] Saini, H., Navaei, A., Van Putten, A., Nikkhah, M., 3D cardiac microtissues encapsulated with the Co-culture of cardiomyocytes and cardiac fibroblasts. Adv. Healthc. Mater. 4:13 (2015), 1961–1971.
67. [67] Arya, A.D., Hallur, P.M., Karkisaval, A.G., Gudipati, A., Rajendiran, S., Dhavale, V., Ramachandran, B., Jayaprakash, A., Gundiah, N., Chaubey, A., Gelatin methacrylate hydrogels as biomimetic three-dimensional matrixes for modeling breast cancer invasion and chemoresponse in vitro. ACS Appl. Mater Interfaces 8:34 (2016), 22005–22017.
68. [68] Bahney, C., Lujan, T., Hsu, C., Bottlang, M., West, J., Johnstone, B., Visible light photoinitiation of mesenchymal stem cell-laden bioresponsive hydrogels. Eur. cells Mater. 22 (2011), 43–55.
69. [69] B.J. Klotz, D. Gawlitta, A.J.W.P. Rosenberg, J. Malda, F.P.W. Melchels, Gelatin-methacryloyl hydrogels: towards biofabrication-based tissue repair, Trends Biotechnol. 34(5) 394–407.
70. [70] Drifka, C.R., Eliceiri, K.W., Weber, S.M., Kao, W.J., A bioengineered heterotypic stroma–cancer microenvironment model to study pancreatic ductal adenocarcinoma. Lab Chip, 13(19), 2013, 3965.
71. [71] Jeong, S.Y., Lee, J.H., Shin, Y., Chung, S., Kuh, H.-J., Co-culture of tumor spheroids and fibroblasts in a collagen matrix-incorporated microfluidic chip mimics reciprocal activation in solid tumor microenvironment. PLOS One, 11(7), 2016, e0159013.
72. [72] Kuo, C.T., Chiang, C.L., Huang, R.Y., Lee, H., Wo, A.M., Configurable 2D and 3D spheroid tissue cultures on bioengineered surfaces with acquisition of epithelial–mesenchymal transition characteristics. NPG Asia Mater., 4(9), 2012, e27.
73. [73] Agastin, S., Giang, U.B.T., Geng, Y., DeLouise, L.A., King, M.R., Continuously perfused microbubble array for 3D tumor spheroid model. Biomicrofluidics, 5(2), 2011, 024110.
74. [74] Ziółkowska, K., Kwapiszewski, R., Stelmachowska, A., Chudy, M., Dybko, A., Brzózka, Z., Development of a three-dimensional microfluidic system for long-term tumor spheroid culture. Sens. Actuators B Chem. 173 (2012), 908–913.
75. [75] Ota, H., Miki, N., Microfluidic experimental platform for producing size-controlled three-dimensional spheroids. Sens. Actuators A Phys. 169:2 (2011), 266–273.
76. [76] Zhang, W., Lee, W.Y., Siegel, D.S., Tolias, P., Zilberberg, J., Patient-specific 3D microfluidic tissue model for multiple myeloma. Tissue Eng. Part C. Methods 20:8 (2014), 663–670.
77. [77] Wang, S., Li, E., Gao, Y., Wang, Y., Guo, Z., He, J., Zhang, J., Gao, Z., Wang, Q., Study on invadopodia formation for lung carcinoma invasion with a microfluidic 3D culture device. PLoS One, 8(2), 2013, e56448.
78. [78] Sung, K.E., Su, X., Berthier, E., Pehlke, C., Friedl, A., Beebe, D.J., Understanding the impact of 2D and 3D fibroblast cultures on in vitro breast cancer models. PLoS One, 8(10), 2013, e76373.
79. [79] Sung, K.E., Yang, N., Pehlke, C., Keely, P.J., Eliceiri, K.W., Friedl, A., Beebe, D.J., Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. Integr. Biol. 3:4 (2011), 439–450.
80. [80] Alessandri, K., Sarangi, B.R., Gurchenkov, V.V., Sinha, B., Kiessling, T.R., Fetler, L., Rico, F., Scheuring, S., Lamaze, C., Simon, A., Geraldo, S., Vignjevic, D., Domejean, H., Rolland, L., Funfak, A., Bibette, J., Bremond, N., Nassoy, P., Cellular capsules as a tool for multicellular spheroid production and for investigating the mechanics of tumor progression in vitro. Proc. Natl. Acad. Sci. 110:37 (2013), 14843–14848.
81. [81] Rao, W., Zhao, S., Yu, J., Lu, X., Zynger, D.L., He, X., Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsules. Biomaterials 35:27 (2014), 7762–7773.
82. [82] Yeung, P., Sin, H.S., Chan, S., Chan, G.C.F., Chan, B.P., Microencapsulation of neuroblastoma cells and mesenchymal stromal cells in collagen microspheres: a 3D model for cancer cell niche study. PLOS One, 10(12), 2015, e0144139.
83. [83] Jang, M., Koh, I., Lee, S.J., Cheong, J.H., Kim, P., Droplet-based microtumor model to assess cell-ECM interactions and drug resistance of gastric cancer cells. Sci. Rep., 7, 2017, 41541.
84. [84] Okochi, M., Matsumura, T., Shuhei, Yamamoto, Nakayama, E., Jimbow, K., Honda, H., Cell behavior observation and gene expression analysis of melanoma associated with stromal fibroblasts in a three-dimensional magnetic cell culture array. Biotechnol. Prog. 29:1 (2013), 135–142.
85. [85] Okochi, M., Takano, S., Isaji, Y., Senga, T., Hamaguchi, M., Honda, H., Three-dimensional cell culture array using magnetic force-based cell patterning for analysis of invasive capacity of BALB/3T3/v-src. Lab Chip, 9(23), 2009, 3378.
86. [86] Knowlton, S., Onal, S., Yu, C.H., Zhao, J.J., Tasoglu, S., Bioprinting for cancer research. Trends Biotechnol. 33:9 (2015), 504–513.
87. [87] Dai, X., Ma, C., Lan, Q., Xu, T., 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility. Biofabrication, 8(4), 2016, 045005.
88. [88] Zhao, Y., Yao, R., Ouyang, L., Ding, H., Zhang, T., Zhang, K., Cheng, S., Sun, W., Three-dimensional printing of Hela cells for cervical tumor model in vitro. Biofabrication, 6(3), 2014, 035001.
89. [89] Derda, R., Tang, S.K.Y., Laromaine, A., Mosadegh, B., Hong, E., Mwangi, M., Mammoto, A., Ingber, D.E., Whitesides, G.M., Multizone paper platform for 3D cell cultures. PloS One, 6(5), 2011, e18940.
90. [90] Hribar, K.C., Finlay, D., Ma, X., Qu, X., Ondeck, M.G., Chung, P.H., Zanella, F., Engler, A.J., Sheikh, F., Vuori, K., Chen, S.C., Nonlinear 3D projection printing of concave hydrogel microstructures for long-term multicellular spheroid and embryoid body culture. Lab Chip 15:11 (2015), 2412–2418.
91. [91] Albritton, J.L., Roybal, J.D., Paulsen, S.J., Calafat, N.J., Flores-Zaher, J.A., Farach-Carson, M.C., Gibbons, D.L., Miller, J.S., Ultrahigh-throughput generation and characterization of cellular aggregates in laser-ablated microwells of poly(dimethylsiloxane). RSC Adv. 6:11 (2016), 8980–8991.
92. [92] Chahal, D., Ahmadi, A., Cheung, K.C., Improving piezoelectric cell printing accuracy and reliability through neutral buoyancy of suspensions. Biotechnol. Bioeng. 109:11 (2012), 2932–2940.
93. [93] Guo, F., Mao, Z., Chen, Y., Xie, Z., Lata, J.P., Li, P., Ren, L., Liu, J., Yang, J., Dao, M., Suresh, S., Huang, T.J., Three-dimensional manipulation of single cells using surface acoustic waves. Proc. Natl. Acad. Sci. 113:6 (2016), 1522–1527.
94. [94] Bumpers, H.L., Janagama, D.G., Manne, U., Basson, M.D., Katkoori, V., Nanomagnetic levitation three-dimensional cultures of breast and colorectal cancers. J. Surg. Res. 194:2 (2015), 319–326.
95. [95] Sokol, E.S., Miller, D.H., Breggia, A., Spencer, K.C., Arendt, L.M., Gupta, P.B., Growth of human breast tissues from patient cells in 3D hydrogel scaffolds. Breast Cancer Res., 18(1), 2016.
96. [96] Romero-Lopez, M., Trinh, A.L., Sobrino, A., Hatch, M.M., Keating, M.T., Fimbres, C., Lewis, D.E., Gershon, P.D., Botvinick, E.L., Digman, M., Lowengrub, J.S., Hughes, C.C., Recapitulating the human tumor microenvironment: colon tumor-derived extracellular matrix promotes angiogenesis and tumor cell growth. Biomaterials 116 (2017), 118–129.
97. [97] Brancato, V., Garziano, A., Gioiella, F., Urciuolo, F., Imparato, G., Panzetta, V., Fusco, S., Netti, P.A., 3D is not enough: building up a cell instructive microenvironment for tumoral stroma microtissues. Acta Biomater. 47 (2017), 1–13.
98. [98] Sobrino, A., Phan, D.T., Datta, R., Wang, X., Hachey, S.J., Romero-Lopez, M., Gratton, E., Lee, A.P., George, S.C., Hughes, C.C., 3D microtumors in vitro supported by perfused vascular networks. Sci. Rep., 6, 2016, 31589.
99. [99] Carmeliet, P., Jain, R.K., Angiogenesis in cancer and other diseases. Nature 407:6801 (2000), 249–257.
100. [100] Nishida, N., Yano, H., Nishida, T., Kamura, T., Kojiro, M., Angiogenesis in cancer. Vasc. Health Risk Manag. 2:3 (2006), 213–219.
101. [101] Dvorak, H.F., Angiogenesis: update 2005. J. Thromb. Haemost. 3:8 (2005), 1835–1842.
102. [102] Stroock, A.D., Fischbach, C., Microfluidic culture models of tumor angiogenesis. Tissue Eng. Pt A 16:7 (2010), 2143–2146.
103. [103] Verbridge, S.S., Chakrabarti, A., DelNero, P., Kwee, B., Varner, J.D., Stroock, A.D., Fischbach, C., Physicochemical regulation of endothelial sprouting in a 3D microfluidic angiogenesis model. J. Biomed. Mater Res. A 101:10 (2013), 2948–2956.
104. [104] Dvorak, H.F., Tumor stroma, tumor blood vessels, and antiangiogenesis therapy. Cancer J. 21:4 (2015), 237–243.
105. [105] Tonnesen, M.G., Feng, X., Clark, R.A., Angiogenesis in wound healing. J. Investig. Dermatol. Symp. Proc. 5:1 (2000), 40–46.
106. [106] Pollard, J.W., Macrophages define the invasive microenvironment in breast cancer. J. Leukoc. Biol. 84 (2008), 623–630.
107. [107] Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A., Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23:11 (2002), 549–555.
108. [108] Sica, A., Schioppa, T., Mantovani, A., Allavena, P., Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. cancer 42:6 (2006), 717–727.
109. [109] Allavena, P., Sica, A., Solinas, G., Porta, C., Mantovani, A., The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. oncology/hematology 66:1 (2008), 1–9.
110. [110] Balkwill, F., Charles, K.A., Mantovani, A., Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7:3 (2005), 211–217.
111. [111] Nyberg, P., Salo, T., Kalluri, R., Tumor microenvironment and angiogenesis. Front Biosci. 1:13 (2008), 6537–6553.
112. [112] Kniazeva, E., Putnam, A.J., Endothelial cell traction and ECM density influence both capillary morphogenesis and maintenance in 3-D. Am. J. Physiol. - Cell Physiol. 297:1 (2009), C179–C187.
113. [113] Nishiguchi, A., Matsusaki, M., Asano, Y., Shimoda, H., Akashi, M., Effects of angiogenic factors and 3D-microenvironments on vascularization within sandwich cultures. Biomaterials 35:17 (2014), 4739–4748.
114. [114] Moon, J.J., Hahn, M.S., Kim, I., Nsiah, B.A., West, J.L., Micropatterning of poly(ethylene glycol) diacrylate hydrogels with biomolecules to regulate and guide endothelial morphogenesis. Tissue Eng. Part A 15:3 (2009), 579–585.
115. [115] Raghavan, S., Nelson, C.M., Baranski, J.D., Lim, E., Chen, C.S., Geometrically controlled endothelial tubulogenesis in micropatterned gels. Tissue Eng. Pt A 16:7 (2010), 2255–2263.
116. [116] Trkov, S., Eng, G., Di Liddo, R., Parnigotto, P.P., Vunjak-Novakovic, G., Micropatterned three-dimensional hydrogel system to study human endothelial - mesenchymal stem cell interactions. J. Tissue Eng. Regen. M. 4:3 (2010), 205–215.
117. [117] Cross, V.L., Zheng, Y., Choi, N.W., Verbridge, S.S., Sutermaster, B.A., Bonassar, L.J., Fischbach, C., Stroock, A.D., Dense type I collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitro. Biomaterials 31:33 (2010), 8596–8607.
118. [118] Zheng, Y., Chen, J.M., Craven, M., Choi, N.W., Totorica, S., Diaz-Santana, A., Kermani, P., Hempstead, B., Fischbach-Teschl, C., Lopez, J.A., Stroock, A.D., In vitro microvessels for the study of angiogenesis and thrombosis. P Natl. Acad. Sci. U. S. A. 109:24 (2012), 9342–9347.
119. [119] Morgan, J.P., Delnero, P.F., Zheng, Y., Verbridge, S.S., Chen, J.M., Craven, M., Choi, N.W., Diaz-Santana, A., Kermani, P., Hempstead, B., Lopez, J.A., Corso, T.N., Fischbach, C., Stroock, A.D., Formation of microvascular networks in vitro. Nat. Protoc. 8:9 (2013), 1820–1836.
120. [120] Verbridge, S.S., Choi, N.W., Zheng, Y., Brooks, D.J., Stroock, A.D., Fischbach, C., Oxygen-controlled three-dimensional cultures to analyze tumor angiogenesis. Tissue Eng. Part A 16:7 (2010), 2133–2141.
121. [121] DelNero, P., Lane, M., Verbridge, S.S., Kwee, B., Kermani, P., Hempstead, B., Stroock, A., Fischbach, C., 3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways. Biomaterials 55 (2015), 110–118.
122. [122] Hou, Y., Ryu, C.H., Jun, J.A., Kim, S.M., Jeong, C.H., Jeun, S.-S., IL-8 enhances the angiogenic potential of human bone marrow mesenchymal stem cells by increasing vascular endothelial growth factor. Cell Biol. Int. 38:9 (2014), 1050–1059.
123. [123] Chung, S., Sudo, R., Mack, P.J., Wan, C.R., Vickerman, V., Kamm, R.D., Cell migration into scaffolds under co-culture conditions in a microfluidic platform. Lab Chip 9:2 (2009), 269–275.
124. [124] Kim, S., Lee, H., Chung, M., Jeon, N.L., Engineering of functional, perfusable 3D microvascular networks on a chip. Lab Chip 13:8 (2013), 1489–1500.
125. [125] Kim, S., Chung, M., Jeon, N.L., Three-dimensional biomimetic model to reconstitute sprouting lymphangiogenesis in vitro. Biomaterials 78 (2016), 115–128.
126. [126] Kim, J., Chung, M., Kim, S., Jo, D.H., Kim, J.H., Jeon, N.L., Engineering of a biomimetic pericyte-covered 3D microvascular network. Plos One, 10(7), 2015.
127. [127] Baranski, J.D., Chaturvedi, R.R., Stevens, K.R., Eyckmans, J., Carvalho, B., Solorzano, R.D., Yang, M.T., Miller, J.S., Bhatia, S.N., Chen, C.S., Geometric control of vascular networks to enhance engineered tissue integration and function. P Natl. Acad. Sci. U. S. A. 110:19 (2013), 7586–7591.
128. [128] Nguyen, D.H.T., Stapleton, S.C., Yang, M.T., Cha, S.S., Choi, C.K., Galie, P.A., Chen, C.S., Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. P Natl. Acad. Sci. U. S. A. 110:17 (2013), 6712–6717.
129. [129] Miller, J.S., Stevens, K.R., Yang, M.T., Baker, B.M., Nguyen, D.H.T., Cohen, D.M., Toro, E., Chen, A.A., Galie, P.A., Yu, X., Chaturvedi, R., Bhatia, S.N., Chen, C.S., Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat. Mater 11:9 (2012), 768–774.
130. [130] Kolesky, D.B., Truby, R.L., Gladman, A.S., Busbee, T.A., Homan, K.A., Lewis, J.A., 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv. Mater 26:19 (2014), 3124–3130.
131. [131] Attwood, D., Collett, J.H., Tait, C.J., The micellar properties of the poly(oxyethylene) poly(oxypropylene) copolymer Pluronic-F127 in water and electrolyte solution. Int. J. Pharm. 26:1–2 (1985), 25–33.
132. [132] Kolesky, D.B., Homan, K.A., Skylar-Scott, M.A., Lewis, J.A., Three-dimensional bioprinting of thick vascularized tissues. Proc. Natl. Acad. Sci. 113:12 (2016), 3179–3184.
133. [133] Homan, K.A., Kolesky, D.B., Skylar-Scott, M.A., Herrmann, J., Obuobi, H., Moisan, A., Lewis, J.A., Bioprinting of 3D convoluted renal proximal tubules on perfusable chips. Sci. Rep., 6, 2016, 34845.
134. [134] Bray, L.J., Binner, M., Holzheu, A., Friedrichs, J., Freudenberg, U., Hutmacher, D.W., Werner, C., Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumour angiogenesis. Biomaterials 53 (2015), 609–620.
135. [135] Chwalek, K., Tsurkan, M.V., Freudenberg, U., Werner, C., Glycosaminoglycan-based hydrogels to modulate heterocellular communication in in vitro angiogenesis models. Sci. Rep., 4, 2014, 4414.
136. [136] El-Zawahry, A., McKillop, J., Voelkel-Johnson, C., Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts. BMC Cancer, 5, 2005, 2.
137. [137] Zhang, Y., Song, S., Yang, F., Au, J.L., Wientjes, M.G., Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors. J. Pharmacol. Exp. Ther. 299:2 (2001), 426–433.
138. [138] Taubenberger, A.V., Bray, L.J., Haller, B., Shaposhnykov, A., Binner, M., Freudenberg, U., Guck, J., Werner, C., 3D extracellular matrix interactions modulate tumour cell growth, invasion and angiogenesis in engineered tumour microenvironments. Acta Biomater. 36 (2016), 73–85.
139. [139] Verbridge, S.S., Choi, N.W., Zheng, Y., Brooks, D.J., Stroock, A.D., Fischbach, C., Oxygen-controlled three-dimensional cultures to analyze tumor angiogenesis. Tissue Eng. Pt A 16:7 (2010), 2133–2141.
140. [140] McCoy, M.G., Seo, B.R., Choi, S., Fischbach, C., Collagen I hydrogel microstructure and composition conjointly regulate vascular network formation. Acta Biomater. 44 (2016), 200–208.
141. [141] Kalluri, R., Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3:6 (2003), 422–433.
142. [142] Li, A., Dubey, S., Varney, M.L., Dave, B.J., Singh, R.K., IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol. 170:6 (2003), 3369–3376.
143. [143] Kass, L., Erler, J.T., Dembo, M., Weaver, V.M., Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. Int. J. Biochem. Cell Biol. 39:11 (2007), 1987–1994.
144. [144] Bordeleau, F., Mason, B.N., Lollis, E.M., Mazzola, M., Zanotelli, M.R., Somasegar, S., Califano, J.P., Montague, C., LaValley, D.J., Huynh, J., Mencia-Trinchant, N., Negron Abril, Y.L., Hassane, D.C., Bonassar, L.J., Butcher, J.T., Weiss, R.S., Reinhart-King, C.A., Matrix stiffening promotes a tumor vasculature phenotype. Proc. Natl. Acad. Sci. U. S. A. 114:3 (2017), 492–497.
145. [145] Moya, M., Tran, D., George, S.C., An integrated in vitro model of perfused tumor and cardiac tissue. Stem Cell Res. Ther., 4(Suppl 1), 2013, S15.
146. [146] Haier, J., Korb, T., Hotz, B., Spiegel, H.-U., Senninger, N., An intravital model to monitor steps of metastatic tumor cell adhesion within the hepatic microcirculation. J. Gastrointest. Surg. 7:4 (2003), 507–515.
147. [147] Aird, W.C., Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 100:2 (2007), 158–173.
148. [148] Cox, T.R., Erler, J.T., Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis. Models Mech. 4:2 (2011), 165–178.
149. [149] Friedl, P., Wolf, K., Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3:5 (2003), 362–374.
150. [150] Friedl, P., Alexander, S., Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147:5 (2011), 992–1009.
151. [151] Hecht, I., Bar-El, Y., Balmer, F., Natan, S., Tsarfaty, I., Schweitzer, F., Ben-Jacob, E., Tumor invasion optimization by mesenchymal-amoeboid heterogeneity. Sci. Rep., 5, 2015, 10622.
152. [152] Clark, A.G., Vignjevic, D.M., Modes of cancer cell invasion and the role of the microenvironment. Curr. Opin. Cell Biol. 36 (2015), 13–22.
153. [153] Roussos, E.T., Condeelis, J.S., Patsialou, A., Chemotaxis in cancer. Nat. Rev. Cancer 11:8 (2011), 573–587.
154. [154] Khamis, Z.I., Sahab, Z.J., Sang, Q.X., Active roles of tumor stroma in breast cancer metastasis. Int. J. Breast Cancer, 2012, 2012, 574025.
155. [155] Johnstone, C.N., Chand, A., Putoczki, T.L., Ernst, M., Emerging roles for IL-11 signaling in cancer development and progression: focus on breast cancer. Cytokine Growth Factor Rev. 26:5 (2015), 489–498.
156. [156] Condeelis, J., Pollard, J.W., Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124:2 (2006), 263–266.
157. [157] Shafqat-Abbasi, H., Kowalewski, J.M., Kiss, A., Gong, X., Hernandez-Varas, P., Berge, U., Jafari-Mamaghani, M., Lock, J.G., Strömblad, S., An analysis toolbox to explore mesenchymal migration heterogeneity reveals adaptive switching between distinct modes. eLife, 5, 2016, e11384.
158. [158] Paňková, K., Rösel, D., Novotný, M., Brábek, J., The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells. Cell. Mol. Life Sci. 67:1 (2010), 63–71.
159. [159] Stetler-Stevenson, W.G., Aznavoorian, S., Liotta, L.A., Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9, 1993.
160. [160] Jimenez Valencia, A.M., Wu, P.H., Yogurtcu, O.N., Rao, P., DiGiacomo, J., Godet, I., He, L., Lee, M.-H., Gilkes, D., Sun, S.X., Wirtz, D., Collective cancer cell invasion induced by coordinated contractile stresses. 2015.
161. [161] Carey, S.P., Starchenko, A., McGregor, A.L., Reinhart-King, C.A., Leading malignant cells initiate collective epithelial cell invasion in a three-dimensional heterotypic tumor spheroid model. Clin. Exp. Metastasis 30:5 (2013), 615–630.
162. [162] Kopanska, K.S., Alcheikh, Y., Staneva, R., Vignjevic, D., Betz, T., Tensile forces originating from cancer spheroids facilitate tumor invasion. PLoS One, 11(6), 2016, e0156442.
163. [163] McLane, J.S., Ligon, L.A., Stiffened extracellular matrix and signaling from stromal fibroblasts via osteoprotegerin regulate tumor cell invasion in a 3-D tumor in situ model. Cancer Microenviron. 9:2–3 (2016), 127–139.
164. [164] Guzman, A., Sanchez Alemany, V., Nguyen, Y., Zhang, C.R., Kaufman, L.J., A novel 3D in vitro metastasis model elucidates differential invasive strategies during and after breaching basement membrane. Biomaterials 115 (2017), 19–29.
165. [165] Kraning-Rush, C.M., Carey, S.P., Lampi, M.C., Reinhart-King, C.A., Microfabricated collagen tracks facilitate single cell metastatic invasion in 3D. Integr. Biol. (Camb) 5:3 (2013), 606–616.
166. [166] Nelson, C.M., Inman, J.L., Bissell, M.J., Three-dimensional lithographically defined organotypic tissue arrays for quantitative analysis of morphogenesis and neoplastic progression. Nat. Protoc. 3:4 (2008), 674–678.
167. [167] Carey, S.P., Rahman, A., Kraning-Rush, C.M., Romero, B., Somasegar, S., Torre, O.M., Williams, R.M., Reinhart-King, C.A., Comparative mechanisms of cancer cell migration through 3D matrix and physiological microtracks. Am. J. Physiol. Cell Physiol. 308:6 (2015), C436–C447.
168. [168] Piotrowski-Daspit, A.S., Tien, J., Nelson, C.M., Interstitial fluid pressure regulates collective invasion in engineered human breast tumors via Snail, vimentin, and E-cadherin. Integr. Biol. 8:3 (2016), 319–331.
169. [169] Singh, M., Mukundan, S., Jaramillo, M., Oesterreich, S., Sant, S., Three-dimensional breast cancer models mimic hallmarks of size-induced tumor progression. Cancer Res. 76:13 (2016), 3732–3743.
170. [170] Zhang, Y., Zhou, L., Qin, L., High-throughput 3D cell invasion chip enables accurate cancer metastatic assays. J. Am. Chem. Soc. 136:43 (2014), 15257–15262.
171. [171] Hoffmann, J.C., West, J.L., Three-dimensional photolithographic micropatterning: a novel tool to probe the complexities of cell migration. Integr. Biol. Quant. Biosci. Nano Macro 5:5 (2013), 817–827.
172. [172] Spagnolo, B., Brunetti, V., Leménager, G., De Luca, E., Sileo, L., Pellegrino, T., Paolo Pompa, P., De Vittorio, M., Pisanello, F., Three-dimensional cage-like microscaffolds for cell invasion studies. Sci. Rep., 5, 2015, 10531.
173. [173] Bender, B.F., Aijian, A.P., Garrell, R.L., Digital microfluidics for spheroid-based invasion assays. Lab Chip 16:8 (2016), 1505–1513.
174. [174] Zhu, J., Liang, L., Jiao, Y., Liu, L., Alliance, U.S.-C.P.S.-O., Enhanced invasion of metastatic cancer cells via extracellular matrix interface. PLoS One, 10(2), 2015, e0118058.
175. [175] Huang, Y.L., Tung, C.K., Zheng, A., Kim, B.J., Wu, M., Interstitial flows promote amoeboid over mesenchymal motility of breast cancer cells revealed by a three dimensional microfluidic model. Integr. Biol. (Camb) 7:11 (2015), 1402–1411.
176. [176] Bischel, L.L., Beebe, D.J., Sung, K.E., Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure. BMC Cancer, 15, 2015, 12.
177. [177] Trietsch, S.J., Israels, G.D., Joore, J., Hankemeier, T., Vulto, P., Microfluidic titer plate for stratified 3D cell culture. Lab Chip 13:18 (2013), 3548–3554.
178. [178] Gioiella, F., Urciuolo, F., Imparato, G., Brancato, V., Netti, P.A., An engineered breast cancer model on a chip to replicate ECM-activation in vitro during tumor progression. Adv. Healthc. Mater 5:23 (2016), 3074–3084.
179. [179] Drifka, C.R., Loeffler, A.G., Esquibel, C.R., Weber, S.M., Eliceiri, K.W., Kao, W.J., Human pancreatic stellate cells modulate 3D collagen alignment to promote the migration of pancreatic ductal adenocarcinoma cells. Biomed. Microdevices, 18(6), 2016, 105.
180. [180] Stroka, K.M., Jiang, H., Chen, S.-H., Tong, Z., Wirtz, D., Sun, S.X., Konstantopoulos, K., Water permeation drives tumor cell migration in confined microenvironments. Cell 157:3 (2014), 611–623.
181. [181] Derda, R., Laromaine, A., Mammoto, A., Tang, S.K.Y., Mammoto, T., Ingber, D.E., Whitesides, G.M., Paper-supported 3D cell culture for tissue-based bioassays. Proc. Natl. Acad. Sci. 106:44 (2009), 18457–18462.
182. [182] Mosadegh, B., Dabiri, B.E., Lockett, M.R., Derda, R., Campbell, P., Parker, K.K., Whitesides, G.M., Three-dimensional paper-based model for cardiac ischemia. Adv. Healthc. Mater. 3:7 (2014), 1036–1043.
183. [183] Camci-Unal, G., Newsome, D., Eustace, B.K., Whitesides, G.M., Fibroblasts enhance migration of human lung cancer cells in a paper-based coculture system. Adv. Healthc. Mater, 5(6), 2016 641-7, 626.
184. [184] Mosadegh, B., Lockett, M.R., Minn, K.T., Simon, K.A., Gilbert, K., Hillier, S., Newsome, D., Li, H., Hall, A.B., Boucher, D.M., Eustace, B.K., Whitesides, G.M., A paper-based invasion assay: assessing chemotaxis of cancer cells in gradients of oxygen. Biomaterials 52 (2015), 262–271.
185. [185] Simon, K.A., Park, K.M., Mosadegh, B., Subramaniam, A.B., Mazzeo, A.D., Ngo, P.M., Whitesides, G.M., Polymer-based mesh as supports for multi-layered 3D cell culture and assays. Biomaterials 35:1 (2014), 259–268.
186. [186] Simon, K.A., Mosadegh, B., Minn, K.T., Lockett, M.R., Mohammady, M.R., Boucher, D.M., Hall, A.B., Hillier, S.M., Udagawa, T., Eustace, B.K., Whitesides, G.M., Metabolic response of lung cancer cells to radiation in a paper-based 3D cell culture system. Biomaterials 95 (2016), 47–59.
187. [187] Truong, A.S., Lochbaum, C.A., Boyce, M.W., Lockett, M.R., Tracking the invasion of small numbers of cells in paper-based assays with quantitative PCR. Anal. Chem. 87:22 (2015), 11263–11270.
188. [188] Okochi, M., Matsumura, T., Honda, H., Magnetic force-based cell patterning for evaluation of the effect of stromal fibroblasts on invasive capacity in 3D cultures. Biosens. Bioelectron. 42 (2013), 300–307.
189. [189] Ma, Y., Pan, J.Z., Zhao, S.P., Lou, Q., Zhu, Y., Fang, Q., Microdroplet chain array for cell migration assays. Lab Chip 16:24 (2016), 4658–4665.
190. [190] Schneider, J., Bachmann, T., Franco, D., Richner, P., Galliker, P., Tiwari, M.K., Ferrari, A., Poulikakos, D., A novel 3D integrated platform for the high-resolution study of cell migration plasticity. Macromol. Biosci. 13:8 (2013), 973–983.
191. [191] Friedl, P., Wolf, K., Plasticity of cell migration: a multiscale tuning model. J. Cell Biol., 188, 2010.
192. [192] Panagiotakopoulou, M., Bergert, M., Taubenberger, A., Guck, J., Poulikakos, D., Ferrari, A., A nanoprinted model of interstitial cancer migration reveals a link between cell deformability and proliferation. ACS Nano 10:7 (2016), 6437–6448.
193. [193] Zielke, N., Edgar, B.A., FUCCI sensors: powerful new tools for analysis of cell proliferation. Wiley Interdiscip. Rev. Dev. Biol. 4:5 (2015), 469–487.
194. [194] Lobo, N.A., Shimono, Y., Qian, D., Clarke, M.F., The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 23:1 (2007), 675–699.
195. [195] Lee, J., Abdeen, A.A., Wycislo, K.L., Fan, T.M., Kilian, K.A., Interfacial geometry dictates cancer cell tumorigenicity. Nat. Mater. 15 (2016), 856–862.
196. [196] Nikkhah, M., Strobl, J.S., Vita, R.D., Agah, M., The cytoskeletal organization of breast carcinoma and fibroblast cells inside three dimensional (3-D) isotropic silicon microstructures. Biomaterials 31:16 (2010), 4552–4561.
197. [197] Nikkhah, M., Strobl, J.S., Peddi, B., Agah, M., Cytoskeletal role in differential adhesion patterns of normal fibroblasts and breast cancer cells inside silicon microenvironments. Biomed. Microdevices 11:3 (2009), 585–595.
198. [198] Zervantonakis, I.K., Hughes-Alford, S.K., Charest, J.L., Condeelis, J.S., Gertler, F.B., Kamm, R.D., Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc. Natl. Acad. Sci. 109:34 (2012), 13515–13520.
199. [199] Chiang, S.P.H., Cabrera, R.M., Segall, J.E., Tumor cell intravasation. Am. J. Physiol. - Cell Physiol. 311:1 (2016), C1–C14.
200. [200] Weinberg, R.A., Mechanisms of malignant progression. Carcinogenesis 29:6 (2008), 1092–1095.
201. [201] Valastyan, S., Weinberg, R.A., Tumor metastasis: molecular insights and evolving paradigms. Cell 147:2 (2011), 275–292.
202. [202] van Zijl, F., Krupitza, G., Mikulits, W., Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat. Res. Rev. Mutat. Res. 728:1–2 (2011), 23–34.
203. [203] Bockhorn, M., Jain, R.K., Munn, L.L., Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?. Lancet Oncol. 8:5 (2007), 444–448.
204. [204] Wong, S.Y., Hynes, R.O., Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?. Cell Cycle 5:8 (2006), 812–817.
205. [205] Spano, D., Heck, C., De Antonellis, P., Christofori, G., Zollo, M., Molecular networks that regulate cancer metastasis. Semin. Cancer Biol. 22:3 (2012), 234–249.
206. [206] Paduch, R., The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell. Oncol. 39:5 (2016), 397–410.
207. [207] Noy, R., Pollard, J.W., Tumor-associated macrophages: from mechanisms to therapy. Immunity 41:1 (2014), 49–61.
208. [208] Reymond, N., d’Água, B.B., Ridley, A.J., Crossing the endothelial barrier during metastasis. Nat. Rev. Cancer 13:12 (2013), 858–870.
209. [209] Buxton, I.L.O., Yokdang, N., Matz, R.M., Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis. Cancer Lett. 291:2 (2010), 131–141.
210. [210] Weidner, N., New paradigm for vessel intravasation by tumor cells. Am. J. Pathol. 160:6 (2002), 1937–1939.
211. [211] Williams, C.B., Yeh, E.S., Soloff, A.C., Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. NPJ Breast Cancer, 2, 2016.
212. [212] Pisano, M., Triacca, V., Barbee, K.A., Swartz, M.A., An in vitro model of the tumor–lymphatic microenvironment with simultaneous transendothelial and luminal flows reveals mechanisms of flow enhanced invasion. Integr. Biol. 7:5 (2015), 525–533.
213. [213] Acosta, M.A., Jiang, X., Huang, P.-K., Cutler, K.B., Grant, C.S., Walker, G.M., Gamcsik, M.P., A microfluidic device to study cancer metastasis under chronic and intermittent hypoxia. Biomicrofluidics, 8(5), 2014, 054117.
214. [214] Lee, H., Park, W., Ryu, H., Jeon, N.L., A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasationa. Biomicrofluidics, 8(5), 2014, 054102.
215. [215] Wong, A.D., Searson, P.C., Live-cell imaging of invasion and intravasation in an artificial microvessel platform. Cancer Res. 74:17 (2014), 4937–4945.
216. [216] Ehsan, S.M., Welch-Reardon, K.M., Waterman, M.L., Hughes, C.C.W., George, S.C., A three-dimensional in vitro model of tumor cell intravasation. Integr. Biol. 6:6 (2014), 603–610.
217. [217] Yamamoto, S., Hotta, M.M., Okochi, M., Honda, H., Effect of vascular formed endothelial cell network on the invasive capacity of melanoma using the in vitro 3D Co-culture patterning model. PLoS One, 9(7), 2014, e103502.
218. [218] Han, W., Chen, S., Yuan, W., Fan, Q., Tian, J., Wang, X., Chen, L., Zhang, X., Wei, W., Liu, R., Qu, J., Jiao, Y., Austin, R.H., Liu, L., Oriented collagen fibers direct tumor cell intravasation. Proc. Natl. Acad. Sci. 113:40 (2016), 11208–11213.
219. [219] Gibot, L., Galbraith, T., Kloos, B., Das, S., Lacroix, D.A., Auger, F.A., Skobe, M., Cell-based approach for 3D reconstruction of lymphatic capillaries in vitro reveals distinct functions of HGF and VEGF-C in lymphangiogenesis. Biomaterials 78 (2016), 129–139.
220. [220] Bruyère, F., Melen-La, L., Berndt, S., Peulen, O., Foidart, J.-M., Noël, A., The Lymphatic Ring Assay: a 3D-culture Model of Lymphangiogenesis. 2008.
221. [221] Bruyère, F., Melen-Lamalle, L., Blacher, S., Roland, G., Thiry, M., Moons, L., Frankenne, F., Carmeliet, P., Alitalo, K., Libert, C., Sleeman, J.P., Foidart, J.-M., Noël, A., Modeling lymphangiogenesis in a three-dimensional culture system. Nat. Methods 5:5 (2008), 431–437.
222. [222] Chen, Y.C., Allen, S.G., Ingram, P.N., Buckanovich, R., Merajver, S.D., Yoon, E., Single-cell migration chip for chemotaxis-based microfluidic selection of heterogeneous cell populations. Sci. Rep., 5, 2015, 9980.
223. [223] Rosenthal, D.T., Iyer, H., Escudero, S., Bao, L., Wu, Z., Ventura, A.C., Kleer, C.G., Arruda, E.M., Garikipati, K., Merajver, S.D., p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior. Cancer Res. 71:20 (2011), 6338–6349.
224. [224] Lee, E., Song, H.G., Chen, C.S., Biomimetic on-a-chip platforms for studying cancer metastasis. Curr. Opin. Chem. Eng. 11 (2016), 20–27.
225. [225] Arvanitis, C., Khuon, S., Spann, R., Ridge, K.M., Chew, T.L., Structure and biomechanics of the endothelial transcellular circumferential invasion array in tumor invasion. PLoS One, 9(2), 2014, e89758.
226. [226] Khuon, S., Liang, L., Dettman, R.W., Sporn, P.H.S., Wysolmerski, R.B., Chew, T.L., Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: a three-dimensional FRET study. J. Cell Sci. 123:3 (2010), 431–440.
227. [227] Rho, J.H., Mead, J.R., Wright, W.S., Brenner, D.E., Stave, J.W., Gildersleeve, J.C., Lampe, P.D., Discovery of sialyl Lewis A and Lewis X modified protein cancer biomarkers using high density antibody arrays. J. Proteomics 96 (2014), 291–299.
228. [228] Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert, W.E., Goldbrunner, R., Herms, J., Winkler, F., Real-time imaging reveals the single steps of brain metastasis formation. Nat. Med. 16:1 (2010), 116–122.
229. [229] Paget, S., The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 8:2 (1989), 98–101.
230. [230] Ewing, J., Neoplastic Diseases: a Treatise on Tumors. 1922, WB Saunders Company.
231. [231] Fidler, I.J., The pathogenesis of cancer metastasis: the ’seed and soil’ hypothesis revisited. Nat. Rev. Cancer 3:6 (2003), 453–458.
232. [232] Nguyen, D.X., Bos, P.D., Massague, J., Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9:4 (2009), 274–284.
233. [233] Schluter, K., Gassmann, P., Enns, A., Korb, T., Hemping-Bovenkerk, A., Holzen, J., Haier, J., Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am. J. Pathol. 169:3 (2006), 1064–1073.
234. [234] Draffin, J.E., McFarlane, S., Hill, A., Johnston, P.G., Waugh, D.J., CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res. 64:16 (2004), 5702–5711.
235. [235] Teicher, B.A., Fricker, S.P., CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin. cancer Res. Off. J. Am. Assoc. Cancer Res. 16:11 (2010), 2927–2931.
236. [236] Domanska, U.M., Kruizinga, R.C., Nagengast, W.B., Timmer-Bosscha, H., Huls, G., de Vries, E.G., Walenkamp, A.M., A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur. J. cancer 49:1 (2013), 219–230.
237. [237] Staton, C.A., Reed, M.W.R., Brown, N.J., A critical analysis of current in vitro and in vivo angiogenesis assays. Int. J. Exp. Pathol. 90:3 (2009), 195–221.
238. [238] Kramer, N., Walzl, A., Unger, C., Rosner, M., Krupitza, G., Hengstschläger, M., Dolznig, H., In vitro cell migration and invasion assays. Mutat. Res. Rev. Mutat. Res. 752:1 (2013), 10–24.
239. [239] Zhang, Q., Liu, T., Qin, J., A microfluidic-based device for study of transendothelial invasion of tumor aggregates in realtime. Lab Chip 12:16 (2012), 2837–2842.
240. [240] Song, J.W., Cavnar, S.P., Walker, A.C., Luker, K.E., Gupta, M., Tung, Y.C., Luker, G.D., Takayama, S., Microfluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells. PLoS One, 4(6), 2009, e5756.
241. [241] Li, X.J., Valadez, A.V., Zuo, P., Nie, Z., Microfluidic 3D cell culture: potential application for tissue-based bioassays. Bioanalysis 4:12 (2012), 1509–1525.
242. [242] Chaw, K.C., Manimaran, M., Tay, E.H., Swaminathan, S., Multi-step microfluidic device for studying cancer metastasis. Lab Chip 7:8 (2007), 1041–1047.
243. [243] Bersini, S., Gilardi, M., Arrigoni, C., Talo, G., Zamai, M., Zagra, L., Caiolfa, V., Moretti, M., Human in vitro 3D co-culture model to engineer vascularized bone-mimicking tissues combining computational tools and statistical experimental approach. Biomaterials 76 (2016), 157–172.
244. [244] Jeon, J.S., Zervantonakis, I.K., Chung, S., Kamm, R.D., Charest, J.L., In vitro model of tumor cell extravasation. PLoS One, 8(2), 2013, e56910.
245. [245] Bersini, S., Jeon, J.S., Dubini, G., Arrigoni, C., Chung, S., Charest, J.L., Moretti, M., Kamm, R.D., A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. Biomaterials 35:8 (2014), 2454–2461.
246. [246] Jeon, J.S., Bersini, S., Gilardi, M., Dubini, G., Charest, J.L., Moretti, M., Kamm, R.D., Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc. Natl. Acad. Sci. U. S. A. 112:1 (2015), 214–219.
247. [247] Chen, M.B., Whisler, J.A., Jeon, J.S., Kamm, R.D., Mechanisms of tumor cell extravasation in an in vitro microvascular network platform. Integr. Biol. (Camb) 5:10 (2013), 1262–1271.
248. [248] Chen, M.B., Lamar, J.M., Li, R., Hynes, R.O., Kamm, R.D., Elucidation of the roles of tumor integrin beta1 in the extravasation stage of the metastasis cascade. Cancer Res. 76:9 (2016), 2513–2524.
249. [249] Gilardi, M., Bersini, S., Kamm, R.D., Moretti, M., Vanoni, M., Abstract PR07: dissection of cancer cells extravasation through human vascularized 3D microfluidic model: the major role of talin-1. Cancer Res., 76(7 Supplement), 2016 PR07–PR07.
250. [250] Boussommier, A., Kamm, R.D., Abstract B165: characterizing the role of macrophages in breast cancer cell extravasation in 3D microfluidic models. Cancer Immunol. Res., 4(1 Supplement), 2016 B165–B165.
251. [251] Boussommier-Calleja, A., Kamm, R.D., Abstract A126: the role of macrophages and monocytes during cancer cell extravasation in 3D vascularized microfluidic models. Cancer Immunol. Res., 4(11 Supplement), 2016 A126–A126.
252. [252] Cui, X., Guo, W., Sun, Y., Sun, B., Hu, S., Sun, D., Lam, R.H.W., A microfluidic device for isolation and characterization of transendothelial migrating cancer cells. Biomicrofluidics, 11(1), 2017, 014105.
253. [253] Spiegel, A., Brooks, M.W., Houshyar, S., Reinhardt, F., Ardolino, M., Fessler, E., Chen, M.B., Krall, J.A., DeCock, J., Zervantonakis, I.K., Iannello, A., Iwamoto, Y., Cortez-Retamozo, V., Kamm, R.D., Pittet, M.J., Raulet, D.H., Weinberg, R.A., Neutrophils suppress intraluminal NK cell-mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells. Cancer Discov. 6:6 (2016), 630–649.
254. [254] Yoneda, T., Hiraga, T., Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem. Biophys. Res. Commun. 328:3 (2005), 679–687.
255. [255] Peinado, H., Lavotshkin, S., Lyden, D., The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin. Cancer Biol. 21:2 (2011), 139–146.
256. [256] Barney, L.E., Dandley, E.C., Jansen, L.E., Reich, N.G., Mercurio, A.M., Peyton, S.R., A cell-ECM screening method to predict breast cancer metastasis. Integr. Biol. (Camb) 7:2 (2015), 198–212.
257. [257] Trédan, O., Galmarini, C.M., Patel, K., Tannock, I.F., Drug resistance and the solid tumor microenvironment. J. Natl. Cancer Inst. 99:19 (2007), 1441–1454.
258. [258] Nakamura, Y., Mochida, A., Choyke, P.L., Kobayashi, H., Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?. Bioconjug. Chem. 27:10 (2016), 2225–2238.
259. [259] Kim, T.-H., Mount, C.W., Gombotz, W.R., Pun, S.H., The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles. Biomaterials 31:28 (2010), 7386–7397.
260. [260] Xu, X., Sabanayagam, C.R., Harrington, D.A., Farach-Carson, M.C., Jia, X., A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics. Biomaterials 35:10 (2014), 3319–3330.
261. [261] Ham, S.L., Joshi, R., Thakuri, P.S., Tavana, H., Liquid-based three-dimensional tumor models for cancer research and drug discovery. Exp. Biol. Med. 241:9 (2016), 939–954.
262. [262] LaBarbera, D.V., Reid, B.G., Yoo, B.H., The multicellular tumor spheroid model for high-throughput cancer drug discovery. Expert Opin. Drug Discov. 7:9 (2012), 819–830.
263. [263] Ham, S.L., Joshi, R., Luker, G.D., Tavana, H., Engineered breast cancer cell spheroids reproduce biologic properties of solid tumors. Adv. Healthc. Mater. 5:21 (2016), 2788–2798.
264. [264] Nirmalanandhan, V.S., Duren, A., Hendricks, P., Vielhauer, G., Sittampalam, G.S., Activity of anticancer agents in a three-dimensional cell culture model. ASSAY Drug Dev. Technol. 8:5 (2010), 581–590.
265. [265] Kunz-Schughart, L.A., Freyer, J.P., Hofstaedter, F., Ebner, R., The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J. Biomol. Screen. 9:4 (2004), 273–285.
266. [266] Minchinton, A.I., Tannock, I.F., Drug penetration in solid tumours. Nat. Rev. Cancer 6:8 (2006), 583–592.
267. [267] Nikkhah, M., Strobl, J.S., Schmelz, E.M., Roberts, P.C., Zhou, H., Agah, M., MCF10A and MDA-MB-231 human breast basal epithelial cell co-culture in silicon micro-arrays. Biomaterials 32:30 (2011), 7625–7632.
268. [268] Nikkhah, M., Strobl, J.S., Agah, M., Attachment and response of human fibroblast and breast cancer cells to three dimensional silicon microstructures of different geometries. Biomed. Microdevices, 11(2), 2008, 429.
269. [269] Strobl, J.S., Nikkhah, M., Agah, M., Actions of the anti-cancer drug suberoylanilide hydroxamic acid (SAHA) on human breast cancer cytoarchitecture in silicon microstructures. Biomaterials 31:27 (2010), 7043–7050.
270. [270] Lutolf, M.P., Hubbell, J.A., Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotech. 23:1 (2005), 47–55.
271. [271] Hutmacher, D.W., Biomaterials offer cancer research the third dimension. Nat. Mater 9:2 (2010), 90–93.
272. [272] Hongisto, V., Jernström, S., Fey, V., Mpindi, J.P., Kleivi Sahlberg, K., Kallioniemi, O., Perälä, M., High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells. PLOS One, 8(10), 2013, e77232.
273. [273] Lan, S.F., Starly, B., Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities. Toxicol. Appl. Pharmacol. 256:1 (2011), 62–72.
274. [274] Lemmo, S., Atefi, E., Luker, G.D., Tavana, H., Optimization of aqueous biphasic tumor spheroid microtechnology for anti-cancer drug testing in 3D culture. Cell. Mol. Bioeng. 7:3 (2014), 344–354.
275. [275] Karlsson, H., Fryknäs, M., Larsson, R., Nygren, P., Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. Exp. Cell Res. 318:13 (2012), 1577–1585.
276. [276] Dufau, I., Frongia, C., Sicard, F., Dedieu, L., Cordelier, P., Ausseil, F., Ducommun, B., Valette, A., Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer. BMC Cancer, 12(1), 2012, 15.
277. [277] Yang, Z., Zhao, X., A 3D model of ovarian cancer cell lines on peptide nanofiber scaffold to explore the cell–scaffold interaction and chemotherapeutic resistance of anticancer drugs. Int. J. Nanomed. 6 (2011), 303–310.
278. [278] Mozzetti, S., Ferlini, C., Concolino, P., Filippetti, F., Raspaglio, G., Prislei, S., Gallo, D., Martinelli, E., Ranelletti, F.O., Ferrandina, G., Scambia, G., Class III β-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin. Cancer Res. 11:1 (2005), 298–305.
279. [279] Kharaishvili, G., Simkova, D., Bouchalova, K., Gachechiladze, M., Narsia, N., Bouchal, J., The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance. Cancer Cell Int., 14(1), 2014, 41.
280. [280] Kultti, A., Li, X., Jiang, P., Thompson, C.B., Frost, G.I., Shepard, H.M., Therapeutic targeting of hyaluronan in the tumor stroma. Cancers 4:3 (2012), 873–903.
281. [281] Tammi, R.H., Kultti, A., Kosma, V.-M., Pirinen, R., Auvinen, P., Tammi, M.I., Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin. Cancer Biol. 18:4 (2008), 288–295.
282. [282] Schwertfeger, K.L., Cowman, M.K., Telmer, P.G., Turley, E.A., McCarthy, J.B., Hyaluronan, inflammation, and breast cancer progression. Front. Immunol., 6, 2015.
283. [283] Thompson, C.B., Shepard, H.M., O'Connor, P.M., Kadhim, S., Jiang, P., Osgood, R.J., Bookbinder, L.H., Li, X., Sugarman, B.J., Connor, R.J., Nadjsombati, S., Frost, G.I., Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models. Mol. Cancer Ther. 9:11 (2010), 3052–3064.
284. [284] Takeuchi, J., Sobue, M., Sato, E., Shamoto, M., Miura, K., Variation in glycosaminoglycan components of breast tumors. Cancer Res. 36:7 pt 1 (1976), 2133–2139.
285. [285] Auvinen, P., Rilla, K., Tumelius, R., Tammi, M., Sironen, R., Soini, Y., Kosma, V.-M., Mannermaa, A., Viikari, J., Tammi, R., Hyaluronan synthases (HAS1–3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival. Breast Cancer Res. Treat. 143:2 (2014), 277–286.
286. [286] Singha, N.C., Nekoroski, T., Zhao, C., Symons, R., Jiang, P., Frost, G.I., Huang, Z., Shepard, H.M., Tumor-associated hyaluronan limits efficacy of monoclonal antibody therapy. Mol. Cancer Ther. 14:2 (2015), 523–532.
287. [287] Tian, X., Azpurua, J., Hine, C., Vaidya, A., Myakishev-Rempel, M., Ablaeva, J., Mao, Z., Nevo, E., Gorbunova, V., Seluanov, A., High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 499:7458 (2013), 346–349.
288. [288] Toole, B.P., Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin. cancer Res. Off. J. Am. Assoc. Cancer Res. 15:24 (2009), 7462–7468.
289. [289] Fong, E.L.S., Martinez, M., Yang, J., Mikos, A.G., Navone, N.M., Harrington, D.A., Farach-Carson, M.C., Hydrogel-based 3D model of patient-derived prostate xenograft tumors suitable for drug screening. Mol. Pharm. 11:7 (2014), 2040–2050.
290. [290] Ham, S.L., Atefi, E., Fyffe, D., Tavana, H., Robotic production of cancer cell spheroids with an aqueous two-phase system for drug testing. J. Vis. Exp. JoVE(98), 2015, e52754.
291. [291] Tavana, H., Jovic, A., Mosadegh, B., Lee, Q.Y., Liu, X., Luker, K., Luker, G., Weiss, S.J., Takayama, S., Nanoliter liquid patterning in aqueous environments for spatially-defined reagent delivery to mammalian cells. Nat. Mater 8:9 (2009), 736–741.
292. [292] Tavana, H., Mosadegh, B., Takayama, S., Polymeric aqueous biphasic systems for non-contact cell printing on cells: engineering heterocellular embryonic stem cell niches. Adv. Mater 22:24 (2010), 2628–2631.
293. [293] Shahi Thakuri, P., Ham, S.L., Luker, G.D., Tavana, H., Multiparametric analysis of oncology drug screening with aqueous two-phase tumor spheroids. Mol. Pharm. 13:11 (2016), 3724–3735.
294. [294] Atefi, E., Lemmo, S., Fyffe, D., Luker, G.D., Tavana, H., High throughput, polymeric aqueous two-phase printing of tumor spheroids. Adv. Funct. Mater. 24:41 (2014), 6509–6515.
295. [295] Ruppen, J., Cortes-Dericks, L., Marconi, E., Karoubi, G., Schmid, R.A., Peng, R., Marti, T.M., Guenat, O.T., A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids. Lab Chip 14:6 (2014), 1198–1205.
296. [296] Bruce, A., Evans, R., Mezan, R., Shi, L., Moses, B.S., Martin, K.H., Gibson, L.F., Yang, Y., Three-dimensional microfluidic tri-culture model of the bone marrow microenvironment for study of acute lymphoblastic leukemia. PLoS One, 10(10), 2015, e0140506.
297. [297] Nair, R.R., Tolentino, J., Hazlehurst, L.A., The bone marrow microenvironment as a sanctuary for minimal residual disease in CML. Biochem. Pharmacol. 80:5 (2010), 602–612.
298. [298] Aung, A., Theprungsirikul, J., Lim, H.L., Varghese, S., Chemotaxis-driven assembly of endothelial barrier in a tumor-on-a-chip platform. Lab Chip 16:10 (2016), 1886–1898.
299. [299] Khademhosseini, A., Langer, R., Borenstein, J., Vacanti, J.P., Microscale technologies for tissue engineering and biology. P Natl. Acad. Sci. U. S. A. 103:8 (2006), 2480–2487.
300. [300] Torisawa, Y.S., Shiku, H., Yasukawa, T., Nishizawa, M., Matsue, T., Multi-channel 3-D cell culture device integrated on a silicon chip for anticancer drug sensitivity test. Biomaterials 26:14 (2005), 2165–2172.
301. [301] Bhatia, S.N., Ingber, D.E., Microfluidic organs-on-chips. Nat. Biotech. 32:8 (2014), 760–772.
302. [302] Lee, J.B., Sung, J.H., Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening. Biotechnol. J. 8:11 (2013), 1258–1266.
303. [303] van Duinen, V., Trietsch, S.J., Joore, J., Vulto, P., Hankemeier, T., Microfluidic 3D cell culture: from tools to tissue models. Curr. Opin. Biotechnol. 35 (2015), 118–126.
304. [304] Choi, I.K., Strauss, R., Richter, M., Yun, C.-O., Lieber, A., Strategies to increase drug penetration in solid tumors. Front. Oncol., 3, 2013, 193.
305. [305] Wilson, W.R., Hay, M.P., Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 11:6 (2011), 393–410.
306. [306] Choi, S.Y.C., Collins, C.C., Gout, P.W., Wang, Y., Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?. J. Pathol. 230:4 (2013), 350–355.
307. [307] Kim, C., Kasuya, J., Jeon, J., Chung, S., Kamm, R.D., A quantitative microfluidic angiogenesis screen for studying anti-angiogenic therapeutic drugs. Lab Chip 15:1 (2015), 301–310.
308. [308] Xu, Z., Gao, Y., Hao, Y., Li, E., Wang, Y., Zhang, J., Wang, W., Gao, Z., Wang, Q., Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer. Biomaterials 34:16 (2013), 4109–4117.
309. [309] Liu, L., Xie, Z., Zhang, W., Fang, S., Kong, J., Jin, D., Li, J., Li, X., Yang, X., Luo, Y., Lin, B., Liu, T., Biomimetic tumor-induced angiogenesis and anti-angiogenic therapy in a microfluidic model. RSC Adv. 6:42 (2016), 35248–35256.
310. [310] Esch, M.B., Smith, A.S.T., Prot, J.-M., Oleaga, C., Hickman, J.J., Shuler, M.L., How multi-organ microdevices can help foster drug development. Adv. Drug Deliv. Rev. 69–70 (2014), 158–169.
311. [311] Verhulsel, M., Vignes, M., Descroix, S., Malaquin, L., Vignjevic, D.M., Viovy, J.-L., A review of microfabrication and hydrogel engineering for micro-organs on chips. Biomaterials 35:6 (2014), 1816–1832.
312. [312] Bettinger, C.J., Borenstein, J.T., Biomaterials-based microfluidics for engineered tissue constructs. Soft Matter 6:20 (2010), 4999–5015.
313. [313] Esch, E.W., Bahinski, A., Huh, D., Organs-on-chips at the frontiers of drug discovery. Nat. Rev. Drug Discov. 14:4 (2015), 248–260.
314. [314] Sung, J.H., Kam, C., Shuler, M.L., A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip. Lab Chip 10:4 (2010), 446–455.
315. [315] Chaudhuri, O., Koshy, S.T., Branco da Cunha, C., Shin, J., Verbeke, C.S., Allison, K.H., Mooney, D.J., Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium. Nat. Mater. 13 (2014), 970–978.
316. [316] Yates, L.R., Gerstung, M., Knappskog, S., Desmedt, C., Gundem, G., Van Loo, P., Aas, T., Alexandrov, L.B., Larsimont, D., Davies, H., Li, Y., Ju, Y.S., Ramakrishna, M., Haugland, H.K., Lilleng, P.K., Nik-Zainal, S., McLaren, S., Butler, A., Martin, S., Glodzik, D., Menzies, A., Raine, K., Hinton, J., Jones, D., Mudie, L.J., Jiang, B., Vincent, D., Greene-Colozzi, A., Adnet, P.Y., Fatima, A., Maetens, M., Ignatiadis, M., Stratton, M.R., Sotiriou, C., Richardson, A.L., Lonning, P.E., Wedge, D.C., Campbell, P.J., Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21:7 (2015), 751–759.